Edwards Lifesciences annual operating margin
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Edwards Lifesciences Operating Margin Growth & History (EW)
Edwards Lifesciences's operating margin was 20.84% for fiscal 2025.
View full Edwards Lifesciences company overviewEdwards Lifesciences annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 20.84% | −4.51 pp |
| 2024 | 2024-12-31 | 25.35% | −0.78 pp |
| 2023 | 2023-12-31 | 26.13% | −7.44 pp |
| 2022 | 2022-12-31 | 33.57% | +1.26 pp |
| 2021 | 2021-12-31 | 32.30% | +11.84 pp |
| 2020 | 2020-12-31 | 20.46% | −5.91 pp |
| 2019 | 2019-12-31 | 26.38% | +6.28 pp |
| 2018 | 2018-12-31 | 20.10% | −11.61 pp |
| 2017 | 2017-12-31 | 31.71% | +6.37 pp |
| 2016 | 2016-12-31 | 25.35% | — |
Edwards Lifesciences quarterly operating margin
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | 29.48% | +2.64 pp |
| Q1 2026 | 2026-03-31 | 28.97% | +1.02 pp |
| Q4 2025 | 2025-12-31 | 9.63% | −12.93 pp |
| Q3 2025 | 2025-09-30 | 19.77% | −6.11 pp |
| Q2 2025 | 2025-06-30 | 26.84% | +0.07 pp |
| Q1 2025 | 2025-03-31 | 27.95% | +1.70 pp |
| Q4 2024 | 2024-12-31 | 22.56% | −6.22 pp |
| Q3 2024 | 2024-09-30 | 25.89% | −3.54 pp |
| Q2 2024 | 2024-06-30 | 26.76% | +6.42 pp |
| Q1 2024 | 2024-03-31 | 26.24% | −0.37 pp |
| Q4 2023 | 2023-12-31 | 28.78% | −17.21 pp |
| Q3 2023 | 2023-09-30 | 29.43% | −1.08 pp |
| Q2 2023 | 2023-06-30 | 20.34% | −13.11 pp |
| Q1 2023 | 2023-03-31 | 26.61% | −6.11 pp |
| Q4 2022 | 2022-12-31 | 45.99% | +17.83 pp |
| Q3 2022 | 2022-09-30 | 30.51% | +0.72 pp |
| Q2 2022 | 2022-06-30 | 33.44% | −5.95 pp |
| Q1 2022 | 2022-03-31 | 32.72% | +1.19 pp |
| Q4 2021 | 2021-12-31 | 28.16% | −1.33 pp |
| Q3 2021 | 2021-09-30 | 29.79% | −1.57 pp |
| Q2 2021 | 2021-06-30 | 39.40% | +57.74 pp |
| Q1 2021 | 2021-03-31 | 31.52% | −0.20 pp |
| Q4 2020 | 2020-12-31 | 29.49% | +3.02 pp |
| Q3 2020 | 2020-09-30 | 31.36% | +4.46 pp |
| Q2 2020 | 2020-06-30 | −18.35% | −42.96 pp |
| Q1 2020 | 2020-03-31 | 31.73% | +4.11 pp |
| Q4 2019 | 2019-12-31 | 26.47% | +27.01 pp |
| Q3 2019 | 2019-09-30 | 26.90% | −0.55 pp |
| Q2 2019 | 2019-06-30 | 24.61% | −2.10 pp |
| Q1 2019 | 2019-03-31 | 27.61% | −0.61 pp |
| Q4 2018 | 2018-12-31 | −0.54% | −38.37 pp |
| Q3 2018 | 2018-09-30 | 27.45% | +1.40 pp |
| Q2 2018 | 2018-06-30 | 26.71% | −1.92 pp |
| Q1 2018 | 2018-03-31 | 28.22% | −5.54 pp |
| Q4 2017 | 2017-12-31 | 37.83% | — |
| Q3 2017 | 2017-09-30 | 26.05% | — |
| Q2 2017 | 2017-06-30 | 28.63% | — |
| Q1 2017 | 2017-03-31 | 33.76% | — |
Edwards Lifesciences operating margin trends
Over the last five reported fiscal years, Edwards Lifesciences's operating margin increased from 20.46% to 20.84%, a change of +0.37 percentage points. The latest reported quarter, Q2 2026, shows 29.48%.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Edwards Lifesciences filings at SEC.gov ↗